Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
José P Henriques
Research Area(s) / Expertise: Job title: Director of the Catheterisation Laboratory
Dr José P Henriques is Director of the Catheterisation Laboratory at the Academic Medical Centre of the University of Amsterdam. He also leads the Academic Medical Centre Mechanical support for Acute Congestive Heart failure in ST elevation myocardial infarction (STEMI) patients (AMC MACH) programme. Dr Henriques gained his MD from the University of Amsterdam and his PhD in medicine from the… View more
JIMPosters
Author(s): Emily Mae L Yap , Alexander A Tuazon Added: 2 years ago

MI/ACS
Author(s): Tim P van de Hoef , Werner Mohl , Ahmed A Khattab , et al Added: 3 years ago
Fast and effective opening of epicardial arteries by thrombolysis or percutaneous coronary intervention (PCI) to restore perfusion to the jeopardised myocardium is considered the cornerstone in the treatment of patients with an acute ST-elevation myocardial infarction (STEMI) leading to a reduction in morbidity and mortality.1 However, despite successful opening of the coronary artery, myocardial… View more

Intervention

MI/ACS
Disparities in ST Elevation Myocardial Infarction
Author(s): Abhijeet Basoor , Gagan Randhawa , John F Cotant , et al Added: 3 years ago
In the US, over the past 30 years, advances in cardiovascular care have resulted in a dramatic decline in mortality and morbidity associated with ST elevation myocardial infarction (STEMI) and non-STEMI.1,2 The overall incidence of coronary heart disease (CHD) has decreased over the last four decades.3 There are various reports about disparities in healthcare and the higher mortality among… View more

Prevention & Chronic Conditions

MI/ACS
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
In this issue of Interventional Cardiology Review there are nine excellent papers, all focusing on issues that have important implications for the clinical practice of interventional cardiologists. Jabbour et al recently published a paper documenting the incidence and possible predictors of delayed coronary obstruction (DCO). Here they summarise the data and go on to discuss how valve design may… View more

Intervention
Author(s): Michael Tsang , Sanjit Jolly Added: 3 years ago
Many advances have been made in the management of ST elevation myocardial infarction (STEMI) over the past three decades.1 This is owed to insight into role that thrombus has in the obstruction of the infarct-related artery (IRA) and the subsequent cascade of the myocardial ischaemia, cell oedema and myocardial necrosis. The institution of reperfusion therapy has revolutionised the care of… View more

Anticoagulation

Standards & Guidelines
Author(s): Carlos E Ruiz Added: 3 years ago
Welcome to Interventional Cardiology – Volume 7 Issue 1. The pace of change in the interventional sphere continues unabated, with a plethora of study data, trial results and breaking news frequently challenging the boundaries of our knowledge. Progress over the last ten years has indeed been great. For us, as practicing physicians, there are in place great structures of learning and support, with… View more

Intervention
Author(s): Sandeep Nathan , Dan Burkhoff , Jerry D Estep , et al Start date: Jul 13, 2023

Heart Failure

Prevention & Chronic Conditions
Fast-track Primary Percutaneous Coronary Intervention
Author(s): Henning Rud Andersen , Christian Juhl Terkelsen Added: 3 years ago
In patients with ST-elevation myocardial infarction (STEMI), reperfusion can either be in the form of fibrinolysis or primary percutaneous coronary intervention (PCI). In recent years, several trials have proven the superiority of primary PCI compared with fibrinolysis,1-5 and it is estimated that primary PCI saves an extra 26 lives per 1,000 treated, when compared with fibrinolysis (Table 1).3… View more

MI/ACS

Intervention
Supersaturated Oxygen (SSO2) Therapy in STEMI Treatments
Author(s): Dan Burkhoff , Sandeep Nathan , Jerry D Estep , et al Added: 2 years ago
Despite advances in reperfusion with primary stenting, progress in STEMI outcomes has stalled over the past 20 years. With 90% of coronary blood flow in the capillaries, the answer might be in the microvasculature. TherOx SSO2 Therapy is the first FDA approved therapy shown to significantly reduce the infarct size in STEMI patients. During this series of webinars on Supersaturated Oxygen … View more

MI/ACS

Intervention